The promise of cancer vaccines
- 1 May 2004
- journal article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 4 (5), 401-411
- https://doi.org/10.1038/nrc1359
Abstract
No abstract availableThis publication has 132 references indexed in Scilit:
- Delivery of tumor-derived RNA for the induction of cytotoxic T-lymphocytesGene Therapy, 2003
- Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8+ T Cell ToleranceThe Journal of Experimental Medicine, 2002
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte ResponsesThe Journal of Experimental Medicine, 2001
- Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in VivoThe Journal of Experimental Medicine, 2001
- Dendritic Cells in Cancer ImmunotherapyAnnual Review of Immunology, 2000
- Regulatory T Cells in AutoimmmunityAnnual Review of Immunology, 2000
- SELECTION OF THE T CELL REPERTOIREAnnual Review of Immunology, 1999
- OX-40: life beyond the effector T cell stageSeminars in Immunology, 1998
- The immune system evolved to discriminate infectious nonself from noninfectious selfImmunology Today, 1992